Search
for
Sort by
Research 841–870 of 1000+
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- No Evidence That Human Papillomavirus Is Responsible for the Aggressive Nature of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma
- Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Determination of the pH Gradient in Hair Follicles of Human Volunteers Using pH-Sensitive Melamine Formaldehyde-Pyranine Nile Blue Microparticles
- Acute and 30-day oral toxicity studies of a novel coccidiostat – ethanamizuril
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- [Study of gonadal hormone drugs in blocking filovirus entry of cells in vitro].
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation
- COVID-19 pandemic and teledermatology in low-income regions
- Development of Suspended Droplet Microextraction Method for Spectrophotometric Determination of Serum Iron
- Dermatologic Changes in Experimental Model of Long COVID
- Post-COVID Telogen Effluvium.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Aqueous Dispersion of Unmodified Fullerene C60: Stimulation of Hair Growth and Study of a New Molecular Target for Interaction
- Repurposed Drugs: Current Trends in Drug Discovery
- Changing Destinies by Fighting Against Bad Luck
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Cemiplimab-Induced Alopecia Areata
- A Comparative study of Regulations of Cell and Gene therapy in US, EU and India
- SYMPTOMATOLOGY AND TREATMENT OF COVID-19 AFFECTING SKIN APPENDAGES: A NARRATIVE REVIEW BEYOND COVID-TOES.
- ISX9, a small molecule targeting Axin, activates Wnt/β-catenin signaling and promotes hair regrowth
- Kaleidoscope
- Malassezia spp. Overgrowth in a Chinchilla Cat
- WARFARIN
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition